Capsaicin-mediated apoptosis of human bladder cancer cells activates dendritic cells via CD91

Nutrition. 2015 Apr;31(4):578-81. doi: 10.1016/j.nut.2014.05.005. Epub 2014 May 29.

Abstract

Objectives: Immunostimulation by anticancer cytotoxic drugs is needed for long-term therapeutic success. Activation of dendritic cells (DCs) is crucial to obtain effective and long-lasting anticancer T-cell mediated immunity. The aim of this study was to explore the effect of capsaicin-mediated cell death of bladder cancer cells on the activation of human monocyte-derived CD1a+ immature DCs.

Methods: Immature DCs (generated from human peripheral blood-derived CD14+ monocytes cultured with granulocyte-macrophage colony stimulating factor and interleukin-4) were cocultured with capsaicin (CPS)-induced apoptotic bladder cancer cells. DC activation was investigated using immunofluorescence and flow cytometric analysis for key surface molecules. In some experiments, CD91 was silenced in immature DCs.

Results: We found that capsaicin-mediated cancer cell apoptosis upregulates CD86 and CD83 expression on DCs, indicating the induction of DC activation. Moreover, silencing of CD91 (a common receptor for damage-associated molecular patterns, such as calreticulin and heat-shock protein-90/70) in immature DCs led to the inhibition of DC activation.

Conclusions: Our data show that CPS-mediated cancer cell apoptosis activates DCs via CD91, suggesting CPS as an attractive candidate for cancer therapy.

Keywords: Apoptosis; Bladder cancer; CD91; Capsaicin; Dendritic cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Immunologic / pharmacology
  • Adjuvants, Immunologic / therapeutic use
  • Antigens, CD / metabolism
  • Antigens, CD1 / metabolism
  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Antineoplastic Agents, Phytogenic / therapeutic use
  • Apoptosis / drug effects*
  • Capsaicin / pharmacology*
  • Capsaicin / therapeutic use
  • Capsicum / chemistry*
  • Dendritic Cells / metabolism*
  • Granulocyte-Macrophage Colony-Stimulating Factor / metabolism
  • Humans
  • Interleukin-4 / metabolism
  • Low Density Lipoprotein Receptor-Related Protein-1 / metabolism*
  • Monocytes / metabolism
  • Phytotherapy
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use
  • Urinary Bladder Neoplasms / drug therapy*
  • Urinary Bladder Neoplasms / immunology
  • Urinary Bladder Neoplasms / metabolism

Substances

  • Adjuvants, Immunologic
  • Antigens, CD
  • Antigens, CD1
  • Antineoplastic Agents, Phytogenic
  • CD1a antigen
  • IL4 protein, human
  • Low Density Lipoprotein Receptor-Related Protein-1
  • Plant Extracts
  • Interleukin-4
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Capsaicin